Plasma biomarkers have now been clinically validated, which could make biological diagnosis of Alzheimer’s disease more accessible. Previously MRI, PET scanning or CSF assays were needed to make a biological diagnosis.
In this Product Explainer, Pharmacist Dr Jacinta Johnson explains the schedule 3 supply of triptans as Pharmacist Only Medicine, and presents several considerations when choosing the appropriate triptan for the acute management of migraine (6 mins).
At the same time as it has attracted support and understanding, attention deficit hyperactivity disorder (ADHD) has invoked passionate debate in recent years. One hot topic is whether ADHD is being over-diagnosed.
This activity will focus on dementia prevention in primary care and will involve sending a link to a standardised questionnaire (CogDrisk) aimed at calculating a risk profile and identifying modifiable risk factors for dementia to all your patients between age 45-65, discussing the results with your patients and reporting on the outcomes in the report template provided.